Mycofoli 720 Tablet contains Mycophenolate Sodium 720 mg, a high-potency immunosuppressant widely prescribed in organ transplant medicine to prevent graft rejection.
This tablet works by inhibiting inosine monophosphate dehydrogenase (IMPDH), suppressing T- and B-lymphocyte proliferation and reducing immune-mediated injury to transplanted organs. It is suitable for patients requiring higher-dose immunosuppression under close medical supervision.
Clinically, Mycofoli 720 Tablet is used in renal, hepatic, and cardiac transplant protocols, often as part of combination therapy with calcineurin inhibitors and corticosteroids, to maintain graft stability and long-term transplant success.
The tablet provides accurate dosing, consistent bioavailability, and reliable therapeutic outcomes, making it ideal for hospitals, transplant centers, specialty pharmacies, and clinics managing intensive post-transplant immunosuppressive therapy.